ADAG

Adagene American Depositary Shares (ADAG)

About Adagene American Depositary Shares (ADAG)

Adagene, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of novel antibody-based cancer immunotherapies. Its dynamic precision library platform is composed of the following proprietary technologies: NEObody, SAFEbody, and POWERbody. The company was founded by Ge Li and Pei Zhi Luo on February 25, 2011 and is headquartered in Suzhou, China.

Details

Daily high
$2.10
Daily low
$1.89
Price at open
$1.89
52 Week High
$4.29
52 Week Low
$1.74
Market cap
85.4M
Dividend yield
0.00%
Volume
35,759
Avg. volume
162,945
P/E ratio
-2.65

Adagene American Depositary Shares News

Details

Daily high
$2.10
Daily low
$1.89
Price at open
$1.89
52 Week High
$4.29
52 Week Low
$1.74
Market cap
85.4M
Dividend yield
0.00%
Volume
35,759
Avg. volume
162,945
P/E ratio
-2.65